ad

Ambica Agarbathies Analyst Review 2027: Sales Up 16% at a Third of Book Value

19 Nov 2026 • 4:15 pm

Ambica Agarbathies Analyst Review 2027: Sales Up 16% at a Third of Book Value

Ambica Agarbathies & Aroma Industries Stock Snapshot (19 Nov 2026)

  • Current Market Price (CMP): ₹22.98
  • 52-Week High / Low: ₹28.80 / ₹20.00
  • Market Capitalisation: ₹41 crore
  • P/E Ratio vs Industry P/E: 11.7 vs 36.5
  • Latest Quarter (Q2 FY27) Revenue: ₹40.23 crore
  • Latest Quarter (Q2 FY27) Net Profit: About ₹1 crore

Quick Answer: The Ambica Agarbathies analyst review 2027 finds no brokerage coverage as of November 2026. Q2 FY27 revenue rose 16.2% to ₹40.23 crore, EBITDA rose about 20% to ₹6.95 crore and net profit was about ₹1 crore, close to ₹0.93 crore a year earlier. The stock traded at ₹22.98 on 19 November 2026, about 0.35 times book value, so any Ambica Agarbathies share price target 2027 view depends on whether higher sales start to lift profit.

The Ambica Agarbathies analyst review 2027 covers Ambica Agarbathies & Aroma Industries, an Andhra Pradesh-based maker of incense sticks and related fragrance products that also runs a hotel business. Readers searching for an Ambica Agarbathies share price target 2027 will not find any named brokerage figure, so this review relies on results and balance sheet data.

Ambica Agarbathies & Aroma Industries traded at ₹22.98 on 19 November 2026, about 20% below its 52-week high of ₹28.80 and about 15% above its low of ₹20. This Ambica Agarbathies analyst review 2027 looks at the quarter and the Ambica Agarbathies stock outlook 2027 for a stock with a market value of only about ₹41 crore.

Click Here – Get Free Investment Predictions

What Analysts Say in the Ambica Agarbathies Analyst Review 2027

Brokerage Rating Target Price Date
No verified coverage Not available Not available As of November 2026

No brokerage covers Ambica Agarbathies. It is a penny stock with a very small market value, no institutional shareholders and thin trading, which keeps it outside research coverage.

Book value per share of about ₹64.94 is the most visible reference point, nearly three times the current price. This Ambica Agarbathies analyst review 2027 explains why the market applies such a steep discount.

Q2 FY27 Results in the Ambica Agarbathies Analyst Review 2027

Metric Q2 FY27 Q2 FY26 Change
Revenue ₹40.23 crore ₹34.63 crore Up 16.2%
EBITDA ₹6.95 crore About ₹5.8 crore Up about 20%
Net profit About ₹1 crore ₹0.93 crore Roughly flat
Q1 FY27 revenue ₹24.65 crore Not applicable Up about 63% QoQ
Q1 FY27 net profit ₹1.11 crore Not applicable Similar level

Sales picked up strongly from the June quarter ahead of the festive season, when demand for incense sticks usually rises. EBITDA margin was about 17%, but most of that operating profit was absorbed by interest and depreciation.

Net profit of about ₹1 crore was barely changed from a year earlier despite higher sales. In this Ambica Agarbathies analyst review 2027, the gap between EBITDA and profit is the key issue for shareholders.

How Ambica Agarbathies Makes Money

Ambica earns most of its revenue from incense products and a smaller share from hospitality.

  • Agarbathies: incense sticks sold in India, the main business with FY26 segment revenue of about ₹115.84 crore.
  • Dhoop and aroma products: related fragrance items sold through the same channels.
  • Hotel division: FY26 segment revenue of about ₹33.70 crore.
  • Segment profit: the incense business earned about ₹6.11 crore while the hotel lost about ₹1.08 crore in FY26.

FY26 revenue was about ₹141 crore with net profit of about ₹3.45 crore. Those numbers frame this Ambica Agarbathies analyst review 2027, because a net margin below 3% leaves little profit for shareholders even in good years.

Incense sticks are a mass-market, low-ticket product with many competitors, from national brands to local makers. Demand is steady and tied to daily prayer and festivals, but pricing power is limited. Larger branded players in the Nifty FMCG universe spend heavily on advertising, which smaller makers like Ambica cannot match.

The hotel division is a separate, loss-making business that takes management attention and capital. A turnaround there, or a decision on its future, would change the profit picture more than small gains in incense sales. Debt to equity of about 0.88 also means interest costs eat into operating profit.

The promoter group raised its stake to 46.08% from 43.41% through a preferential issue, which brought fresh capital into the company. Promoter investment is a supportive sign, though it also adds shares and dilutes other holders slightly.

Growth Triggers in the Ambica Agarbathies Analyst Review 2027

  • Sales growth: revenue up 16.2% in Q2 FY27.
  • Operating profit: EBITDA up about 20% to ₹6.95 crore.
  • Festive season: the December quarter usually sees strong demand.
  • Promoter capital: stake raised to 46.08% through a preferential issue.
  • Deep discount to book: about 0.35 times book value, central to any Ambica Agarbathies share price target 2027 view.

Key Risks in the Ambica Agarbathies Analyst Review 2027

  • Thin margins: net margin below 3% in FY26.
  • Hotel losses: the hospitality unit lost about ₹1.08 crore in FY26.
  • Debt: debt to equity of about 0.88.
  • Competition: strong national incense brands.
  • Penny stock risk: low price and thin trading, a core point in the Ambica Agarbathies analyst review 2027.

Compare Ambica Agarbathies With Other FMCG Stocks on the Univest Screener

Ambica Agarbathies Analyst Review 2027: Stock at a Glance

Metric Value
Share Price (19 Nov 2026) ₹22.98
52-Week High / Low ₹28.80 / ₹20.00
Market Capitalisation About ₹41 crore
P/E (TTM) About 11.7
Industry P/E About 36.5
Price to Book About 0.35
Book Value per Share ₹64.94
Debt to Equity 0.88
FY26 Revenue / Net Profit About ₹141 crore / ₹3.45 crore

The P/E of about 12 is far below the industry level of about 36, and the stock trades at about a third of book value. In this Ambica Agarbathies analyst review 2027, the discount reflects a return on equity of only about 3%, debt and the loss-making hotel.

Shareholding Trend

Holder Dec 2025 Sep 2026 Change
Promoters 43.41% 46.08% Up 2.67 points
Foreign Investors (FII) 0.00% 0.00% No change
Domestic Institutions (DII) 0.00% 0.00% No change
Public 56.59% 53.92% Down 2.67 points

The promoter stake rose by 2.67 points after the preferential issue. There are no institutional investors, which the Ambica Agarbathies analyst review 2027 sees as a sign of very limited professional interest.

Univest iOS App

Univest Android App

What to Watch After the Ambica Agarbathies Analyst Review 2027

  • Festive quarter: December quarter sales and margins.
  • Hotel division: any turnaround or restructuring.
  • Debt: use of preferential issue funds.
  • Profit conversion: net profit against EBITDA.
  • Coverage: any research that sets an Ambica Agarbathies share price target 2027.

Final Word on the Ambica Agarbathies Analyst Review 2027

The Ambica Agarbathies analyst review 2027 shows rising sales, better operating profit and fresh promoter capital, against thin net margins, debt and a loss-making hotel unit. The stock trades at a deep discount to book value and carries penny stock risks.

The Ambica Agarbathies stock outlook 2027 depends on profit conversion and the hotel business. Univest does not give a buy or sell call.

Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions

What does the Ambica Agarbathies analyst review 2027 show?

It shows higher sales with flat profit. Q2 FY27 revenue rose 16.2% to ₹40.23 crore and EBITDA rose about 20% to ₹6.95 crore. Net profit was about ₹1 crore, close to ₹0.93 crore a year earlier.

Is there an Ambica Agarbathies share price target 2027 from brokerages?

No named brokerage target exists as of November 2026. The stock traded at ₹22.98 on 19 November 2026, against book value of about ₹64.94 a share. It is a penny stock with thin trading.

What businesses does Ambica Agarbathies run?

The company makes incense sticks and related aroma products, which brought about ₹115.84 crore of segment revenue in FY26. It also runs a hotel division with about ₹33.70 crore of revenue. The hotel lost about ₹1.08 crore in FY26.

Why did the Ambica Agarbathies promoter stake rise?

The promoter group took part in a preferential issue, raising its stake to 46.08% from 43.41%. This brought fresh capital into the company. It also slightly diluted other shareholders.

Is Ambica Agarbathies stock undervalued based on the Ambica Agarbathies analyst review 2027?

The stock trades at about 0.35 times book value and about 11.7 times earnings, against an industry P/E of about 36.5. Return on equity is only about 3%. Debt and the loss-making hotel explain much of the discount.

What risks does the Ambica Agarbathies analyst review 2027 highlight?

The main risks are thin net margins, debt to equity of about 0.88 and losses in the hotel business. Competition from national incense brands limits pricing. The stock is a low-priced, thinly traded micro-cap.

What should investors track after the Ambica Agarbathies analyst review 2027?

Track December quarter sales during the festive season and how much EBITDA turns into net profit. Watch the hotel division for a turnaround. Use of the preferential issue funds also matters.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down